Lee Chia-Yi, Yang Shun-Fa, Chen Hung-Chi, Chang Chao-Kai
Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Nobel Eye Institute, Taipei, Taiwan.
Int J Med Sci. 2024 Nov 4;21(15):2919-2925. doi: 10.7150/ijms.101341. eCollection 2024.
To evaluate the potential risk factors for poor dry eye disease (DED) outcomes after intense pulse light (IPL) treatment. A retrospective case-control study was conducted, and patients who received IPL were enrolled. A total of 63 eyes were included in the present study after exclusion and were divided into a fair outcome group and a poor outcome group according to posttreatment improvements in DED-related signs and symptoms. The primary outcomes are the pretreatment parameters between the two groups. The Mann‒Whitney U test and generalized linear model were adopted to analyze the differences in pretreatment indices between the two groups. Both the fluorescein stain results and the Schirmer II test results after IPL treatment were significantly better than those before IPL treatment (both P < 0.05). Nevertheless, the overall DED-related symptoms did not significantly improve after IPL treatment (P = 0.834). In terms of indicators of poor outcomes after IPL treatment, the rates of advanced age, female sex, previous refractive surgery, lower pretreatment noninvasive tear break-up time (NITBUT) and greater meibomian gland loss were significantly greater in the poor outcome group (all P < 0.05). Female sex and previous refractive surgery were associated with less improvement in DED-related symptoms (all P < 0.05), whereas advanced age, a lower pretreatment NITBUT and a higher meibomian gland loss rate were related to poor DED sign improvement (all P < 0.05). The major limitations are the retrospective design, small study population, and absence of detailed posttreatment exams. In conclusion old age, female sex, previous refractive surgery, a lower NITBUT, and a higher meibomian gland loss rate are associated with worse outcomes after IPL treatment.
评估强脉冲光(IPL)治疗后干眼症(DED)预后不良的潜在风险因素。进行了一项回顾性病例对照研究,纳入接受IPL治疗的患者。经排除后,本研究共纳入63只眼,并根据DED相关体征和症状的治疗后改善情况分为预后良好组和预后不良组。主要观察指标为两组的治疗前参数。采用曼-惠特尼U检验和广义线性模型分析两组治疗前指标的差异。IPL治疗后的荧光素染色结果和Schirmer II试验结果均显著优于IPL治疗前(均P<0.05)。然而,IPL治疗后总体DED相关症状未显著改善(P = 0.834)。在IPL治疗后预后不良的指标方面,预后不良组的高龄、女性、既往屈光手术史、治疗前较低的非侵入性泪膜破裂时间(NITBUT)和较高的睑板腺缺失率显著更高(均P<0.05)。女性和既往屈光手术史与DED相关症状改善较少有关(均P<0.05),而高龄、治疗前较低的NITBUT和较高的睑板腺缺失率与DED体征改善不佳有关(均P<0.05)。主要局限性在于回顾性设计、研究人群小以及缺乏详细的治疗后检查。总之,高龄、女性、既往屈光手术史、较低的NITBUT和较高的睑板腺缺失率与IPL治疗后较差的预后相关。